Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The study will be a 6-month, open-label, multiple center study in approximately 50 stable subjects diagnosed with schizophrenia or schizoaffective disorder to evaluate the safety, tolerability, and pharmacokinetics of Risperidone and 9-OH-Risperidone following implantation of two or three, 300 mg Risperidone Implants.
Critère d'inclusion
- Schizophrenia,Schizo-affective Disorder